跳至主要内容
临床试验/JPRN-UMIN000022529
JPRN-UMIN000022529已完成3 期

Effects on the pharmacokinetics of L-DOPA formulation by Proton pump inhibitors in patients with Parkinson's disease - Effects on the pharmacokinetics of L-DOPA formulation by Proton pump inhibitors in patients with Parkinson's disease

tano National Hospital, National Hospital Organization0 个研究点目标入组 8 人开始时间: 2016年6月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients who can't take tablets and capsules 2.Patients after gastrectomy 3.Patients who are taking or within two weeks from final taking of H2-receptor antagonists and Proton pump inhibitors 4.Patients who need of administration of proton pump inhibitors in urgently 5.Patients with serious liver failure or renal dysfunction 6.Patients who have hypersensitivity to Nexium10 Capsules 7.Patients who take Combination contraindicated drugs with Nexium10 Capsules(Atazanavir Sulfate,Rilpivirine Hydrochloride) 8.Patients who have Lactose intolerance 9.Patients who are judged as unsuitable for the study by the investigator for the other reasons

研究者

发起方
tano National Hospital, National Hospital Organization

相似试验